Evaluation of the Prognostic Value of Preoperative Quadriceps and Respiratory Muscle Thickness by Ultrasound Measurement in Cardiac and Thoracic Surgery Patients
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DIJON · Jun 7, 2022
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the thickness of certain muscles, like the quadriceps (thigh muscle) and respiratory muscles, can help predict the risk of complications after major heart or lung surgeries in patients aged 65 and older. Researchers want to use ultrasound, a safe imaging technique that doesn’t involve radiation, to measure these muscle groups the day before surgery. By understanding a patient’s muscle mass, they hope to better assess their overall health and readiness for surgery, potentially leading to improved outcomes.
To participate in the study, patients must be 65 years or older and scheduled for elective heart surgery with a heart-lung machine or lung surgery that involves removing part of the lung. Patients who are pregnant, unable to give consent, or have certain medical conditions may not be eligible. Those who join the study will have a simple ultrasound to measure their muscle thickness. This research aims to provide valuable insights that could enhance pre-surgery assessments and ultimately improve patient care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient 65 years or older
- • Patients who have not objected to their inclusion in the study
- • Any patient requiring elective cardiac surgery, with extracorporeal circulation extracorporeal circulation OR
- • Any patient requiring lung surgery with resection of at least one lobe
- Exclusion Criteria:
- • pneumectomy
- • Person who is not affiliated to national health insurance
- • Person subject to a measure of legal protection (curatorship, guardianship)
- • Pregnant, parturient or breastfeeding women
- • Major unable to express consent
- • Persons with amputations of the proximal segment of a lower limb
- • Persons suffering from a pre-existing neuromuscular pathology, tetra or paraplegia
- • Person who must undergo emergency surgery
About Centre Hospitalier Universitaire Dijon
The Centre Hospitalier Universitaire Dijon (CHU Dijon) is a leading academic medical institution in France, dedicated to advancing healthcare through innovative research and clinical trials. With a focus on patient-centered care, CHU Dijon integrates comprehensive medical services with cutting-edge research initiatives across various specialties. The institution is committed to enhancing clinical outcomes and improving health standards by facilitating rigorous scientific investigations and collaborations with national and international partners. By prioritizing ethical practices and adherence to regulatory standards, CHU Dijon aims to contribute significantly to the development of new therapies and medical technologies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dijon, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials